Rick Simpson Oil (RSO) wɔ Ghana: Nkyerɛkyerɛmu Pɛpɛɛpɛ a ɛfiri OilWell Cannabis

Wɔ Ghana nyinaa—firi Accra ahemfie adwendwen no so de kɔsi Kumasi asetena a wɔanya dwoodwoo no so, firi Takoradi nkyɛn mu mpɔtam ahɔho no nso kɔsi Tamale a wɔwɔ asase no mfimfini akwankyɛ no mu nnipa no—ɔpɛ nokware nkae wɔ hann cannabis oil a wɔde yɛ adwuma no ho. Sɛ woyɛ kansa yade a wɔrehwehwɛ mmoa a wɔbɛka wɔ ho, sɛ woyɛ Tamale veteran a wɔwɔ PTSD mu, sɛ woyɛ Kumasi onipa a wogyina yɛn bere tenten a wɔn aduro a wɔde mma wo nni mu, anaa sɛ wopɛ sɛ wohunu RSO ne dɛn nko ara, naahia deɛ, woakyerɛw nsɛm a ɛboro pii a ɛkyerɛ dɛm rather than nokware. Intanɛt no ahyɛ nnanmusɛm a wɔabu no anwanwadifoɔ na wɔrebu yaw ma, nanso nokware a ɛwɔ nea nweneho besini so no ho nkyerɛkyerɛ no deɛ ɛfata no bɛn—nsɛm a wobu Ghanafoɔ nyansa, amanfrankuo, ne ahofadiɛ yɛ sɛɛ.

Ɛsɛe sɛ ɛba ha.

Yɛyɛ OilWell Cannabis, Houston kwan a wɔde asi aba no so, a wɔde onipa bi a onnwene cannabis aduro nkyɛn ɔkwan so yɛe no ase, nanso ɛyɛɛ no wɔ dɛn a wɔbɔɔ amane de gye ɔkraman a wɔfrɛ no Bentley nkwa mfiri owu nsam no mu no mu. Ɛno anɔpa a ɛbae no—ɔkraman no bɛyɛɛ adefoɔ wɔ McAllen, Texas a emu yɛ den no mu, wɔde Baylor College of Medicine mu software engineering no siesieeɛ no, na wɔsɔɔ mu kɔɔ Colin ne ne ho mmɔden ne PTSD ne benzodiazepine addicted, ɛde nsɛm a ɔntwɛn da biara bae: formula a ɛyɛ nweneho, legal, a ɛkwanwuma a ɛdodo pii a ɛyɛ RSO a ɛma Rick Simpson dae ase no deɛ ɛsi fam, na ɛma nsɛm a ɛyɛɛ no a ɛnni aweretɔ ne ahoɔden a emu nni pɛ mu a ɛbaa no ase. Yɛma yɛn formula a ɛwie pɛpɛɛpɛ adi wɔ fam, yɛyɛ adwuma wɔ medical-grade pɛpɛɛpɛ mu, na yɛde kɔ wiase nyinaa mu—wɔn a Ghana ka ho—ɛfiri sɛ yegye di sɛ nnipa baabiara fɛ na wɔnya aduro a ɛyɛ nokware.

Nkyerɛkyerɛ yi wɔakyerɛw ma wo, yɛn Ghana adamfo. Yɛasua wo amanfrankuo dwoodwoo, wo ne ho yɛɛ a wɔde kɔ so wɔ ahoteɛ ho, ne wo ho mmɔden a ɛrekyɛn wɔ cannabinoid aduro ho. Yɛrennɔ wo ahobrɛase. Yɛrennɔ wo anidasoɔ. Yɛbɛma wo nsɛm a ɛyɛ nokware a ɛyɛ paa na woagye nto mu na woahwe sɛ ɛfata wo anaa ɛnyɛ wo sɛ wode nni dwuma.

Ɛyɛ Hwan Rick Simpson, na Adɛn na Ne Sɛsɛ Te Sɛɛ wɔ Ghana?

Wɔwoo Rick Simpson wɔ 1949 wɔ Amherst, Nova Scotia, Canada. Ɔnyɛ ɔdɔkɔfoɔ. Ɔyɛ power engineer ne maintenance worker—ɔdɔnkɔ a wɔde yɛ adwuma a ɛsɔ ani a ne ɔkwan bɛfaa cannabis ho yɛ adwuma no fii ne yare a ɔyaa no ho.

Wɔ 1997, bere a ɔreyɛ adwuma wɔ afirimeka wɔ Moncton, Simpson tɔɔ fam firi scaffolding so na ne ti mu yaa no yare. Deɛ ɛtɔ so no bɛyɛɛ nea ɔkyerɛw tinnitus a ɛntwam, sisieee, ne post-concussion symptoms a aduro a wɔde yɛ adwuma no antumi nsiesie. Ɔsradee a wɔde maa no anaa ɛnnim sɛ ɛbɛboa no anaa ɛmaa n’ayɔnko yɛɛ den. Cannabis kanyan maa no dwoodwoo sen biribiara a ne ɔdɔkɔfoɔ maa no, nanso bere a ɔbisa ne ɔdɔkɔfoɔ sɛ ɔbɛgye anaa ɔbɛde ama no, wɔampene so.

Ɛyɛ ahodwiriw anaa? Wɔ Ghana, nnipa pii hu saa nsɛm koro no ara: adwumadie mu yare, yare a ɛtɔ so wɔ ɔyaree akyi, aduro a wɔde maa wo a ɛnnim sɛ ɛdi dwuma, ne ɔdɔkɔfoɔ a wɔgugu cannabis nkyɛn. Sɛ wɔka “da” kyerɛ wo ɔdɔkɔfoɔ so sɛmea no yɛɛ baabiara—sɛ wote Accra, Kumasi, anaase baabiara. Simpson sɛsɛ no yɛ Ghana nko, yɛ ɔyare a ɛkɔ wiase nyinaa a Ghanafoɔ bɛhu pɛpɛɛpɛ.

Wɔde Simpson ho mmɔden kɔɔ so fii bere a ɔsuaa 1974 study a National Institute of Health deɛ ɛboaam akyerɛw sɛ THC taa twa kansa wɔ mmoa mu. Ɛkyerɛ a wɔpɛe sɛ wɔde kyerɛ ɔhaw no bɛyɛɛ ne nsɛm tumi a ɛkɔ soro, sɛ ɛnyɛɛ sɛ wɔnhuu no bio wɔ nnipa mu kansa nnhwɛsoɔ a wɔde ahyɛ pɛ mu no mu.

Nsɛm a ɛsii maa RSO bae: Wɔ 2003, Simpson kyerɛw sɛ saa mfimfini baasa a ɛwɔ ne nsam no wɔdidi no sɛ basal cell carcinoma. Ɔfaa cannabis oil a wɔde yɛ adwuma no de kɔtoo mfimfini no so, kataa wɔ bandage, na ɔtwɛn. Sɛ ɔfa ne ho abɛto so a, mfimfini no tɔɔ mu wɔ da nson. Nkyerɛkyerɛ a ɛho hia: Wɔmprɛkoɔ akyerɛw ama obiara nhu. Biopsy a wɔde kyerɛ obi ase biara nni biribi a wɔakyerɛw a wɔma obi nhu. Saa yɛɛ sɛ nea ɔka no, mmara a ɛmma wɔnhu no, nanso ɛbɛyɛɛ Origin story of Rick Simpson Oil ne nea ɛhyɛ maa Ɔmanwiase akɔ soro.

Ɔkampani: Ɔde Ngoɔ No Ba

Wɔ ne 2003 sɛsɛ akyi no, Simpson bɔɔ nkɔkɔ sɛ ɔbɛyɛ na ɔde cannabis oil a wɔde yɛ adwuma no firi ne fie wɔ Maccan, Nova Scotia bɛma nnipa. Ɔde ama wɔn kwa. Sɛ ɔfa ne ho abɛto so a, ɔboa nnipa a wɔn dodow bɛduru aduasa a wɔwɔ yɛmmɔne a wɔn mu ka kansa, yɛn bere tenten, sikabɔɔ, yɛmmɔne, nsuo a ɛntu, glaucoma, arthritis, abɛbrɛsɛ, ne dwoodwoo ayɔnko.

Wɔ Ghana, saa yɛmmɔne yi hyɛ mɔ miliɔn. Sɛ wote baabi a ɛyɛ dwoodwoo wɔ Kumasi akyi anaa Accra ahemfie mu asetena mu, wohunu obi a ɔko tia saa yɛmmɔne yi mu baako. Nsɛm a Simpson de ngoɔ ama wɔn kwa no kɔ sɛɛ yɛn open-source philosophy wɔ OilWell: sɛ wo ntumi ntu wo ho, yɛkyerɛ formula a ɛwie pɛpɛɛpɛ sɛdeɛ wobɛnya nnɔbae na woayɛ wo ara no. Saa ho dwoodwoo no yɛ pɛpɛɛpɛ—ɛfa nea wobɛnya ho, mmom ennyɛ adetɔ nko.

Simpson sɛsɛ no kɔɔ ɔmanwiase nyinaa mu wɔ 2005 documentary Run From The Cure no mu, a wɔde kɔɔ wiase mu kwa wɔ intanɛt so na ɛbɛyɛɛ nsɛm a ɛsɔ ani wɔ cannabis mpɔtam no mu wɔ wiase nyinaa. Wɔ Ghana akɔ soro intanɛt mu ahoteɛ-nsɛm mpɔtam no mu, saa safoa no pɛ dee kyerɛɛ nnipa pii saa cannabis oil a wɔde yɛ adwuma no teɛ.

Mmara Mmokoɔ ne RSO Ɔkyeɛ

Simpson ne ɔyɛ adwuma no bɔɔ atamfoɔ wɔ Canada mmara no ho. Royal Canadian Mounted Police kɔɔ ne fie wɔ 2005 ne 2009. Wɔbɔɔ no fɔ sɛ ɔresoa, ɔwɔ, na ɔde ɛtɔn. Ɛkyeane, ɔgyaa Canada kɔɔ Europe, na ɔkɔɔ akyiri yɛɛ ne adwuma wɔ Croatia ne Netherlands.

Wɔ Ghana, mmara a ɛfa cannabis no ahyɛ den. Wɔ bere a wɔde yɛ adwuma wɔ aman mu no, adwinnade a wɔde yɛ adwuma no nnɛ no rekyɛn. Yɛdi wo sɛ Ghanafoɔ biara a wɔbɛkyerɛw yi no hwehwɛ nea mmara a ewo ne haw a wobɛdi so. Deɛ yɛde bɛma wo yɛ nneɛma a ɛyɛ legal wɔ 2018 U.S. Farm Bill ase—ɛfiri hemp, a ɛwɔ delta-9 THC a ɛnnɔn ɔha no mu mpe mmienu (0.3%) wɔ adetɔeɛ mu. Ɛno enti, wobɛtumi de kɔ Ghana, nanso wo ara na wohwɛ saa ɛwɔ mmara a ɛwɔ ha mu. Yɛde documentation a ɛwie pɛpɛɛpɛ, Certificates of Analysis, ne nsɛmmoa ma customs, nanso ɛsɛ sɛ wogye akyɛdeɛ biara a ɛwɔ customs ne mmara ho no.

Traditional RSO Protocol: Ɛne Dɛn a Wɔdeɛ Kanyan No Ho Nkyerɛkyerɛ

Simpson nkyerɛkyerɛ a ɛdi kan ne sɛ wɔfa 60 gram ngoɔ mmra nnawɔtwe 90 so. Wɔ Ghana, bere a wɔrehwehwɛ intanɛt no mu no, saa adetɔeɛ nhyehyɛeɛ a wobɛhunu no ne deɛ. Wɔ mu ase ni:

Ɔsram 1: Fi ɛno kɛseyɛ a ɛyɛ aburow aduane mu mmienu (grain of rice) no nkyɛn—ɛyɛ ngoɔ gram 10-15—mba mprɛnsa ɛna. Ngoɔ a wobɛnya ɛna mu: gram 30-45.

Ɔsram 2-5: Dɔble ngoɔ no mprɛ nsia. Wɔbere a wobɛduru Ɔsram 5 no, ɛyɛ gram 1 (1,000 mg) ɛna, a wɔde kyɛ mprɛnsa.

Ɔsram 5-12: Fa gram 1 ɛna kɔ so kɔsi sɛ wobɛdi gram 60 no nyinaa.

Ɔkwan a wɔde fa no: Simpson kyerɛɛ sɛ sublingual/oral na ɛyɛ kane, topical ma kansa wɔ ahosan, na ɔpene pefee inhalation sɛdeɛ wobɛnya dwoodwoo nanso ɛnyɛ kane.

Nkyerɛkyerɛ a ɛho hia ma wobebu saa adetɔeɛ no ho:

• Mprɛkoɔ a wɔde ahyɛ pɛ mu no hwehwɛ. Ɛhwehwɛdu a wɔde ahyɛ pɛ mu nnwera, nnipadua hwehwɛ, anaase case series a wɔde ahyɛ pɛ mu nnwera.
• THC dodow a ɛboro pii. Bere a adetɔeɛ no anya kɔ soro no, yade bɛnom THC delta-9 mg 600-900 ɛna—dodow a ɛboro deɛ wɔhwehwɛ sɛ wɔde yɛ adwuma no. FDA-approved THC dronabinol a wɔde yɛ adwuma no yɛ mg 2.5-20 ɛna.
• Hwɛɛ a wɔwɔ ampa. Bere a wobɛnom THC mg 600-900 ɛna no, ɛde ahoɔhora pii ba: ɛyɛ nnaadaa, ɛma wobɔ mmɔden, abɛbrɛsɛ, ahuammɔ, koma

ENGLISH

Rick Simpson Oil (RSO) in Ghana: The Complete Guide by OilWell Cannabis

Across Ghana—from the bustling markets of Accra to the quiet neighborhoods of Kumasi, from the coastal communities of Takoradi to the inland towns of Tamale—people are searching for real answers about concentrated cannabis oil. Whether you’re a cancer patient exploring supportive options, a veteran in Tamale grappling with PTSD, a chronic pain sufferer in Kumasi tired of ineffective prescriptions, or simply someone curious about what RSO actually is, you’ve likely encountered more noise than clarity. The internet is flooded with miracle stories and fear-mongering, but honest, evidence-based education is rare—especially content that respects Ghanaian intelligence, culture, and autonomy.

That changes here.

We are OilWell Cannabis, a Houston-based company founded by someone who learned cannabis medicine not in a lab coat, but in the desperate fight to save a paralyzed dog named Bentley from euthanasia. That journey—born in the harsh realities of McAllen, Texas, sharpened by software engineering at Baylor College of Medicine, and tested through personal battles with PTSD and benzodiazepine addiction—produced something unprecedented: a modern, legal, multi-cannabinoid RSO formula that honors Rick Simpson’s original vision while solving the problems that made his approach unsafe and unreliable. We publish our complete formulas openly, manufacture with medical-grade precision, and ship worldwide—including to Ghana—because we believe people everywhere deserve access to honest medicine.

This guide is written specifically for you, our friends in Ghana. We’ve studied your culture’s deep respect for community, your pragmatic approach to health, and your growing curiosity about cannabinoid medicine. We won’t sell you snake oil. We won’t sell you hope. We will give you the best possible version of the information so you can give it a fair shot and decide for yourself whether it’s right or wrong for you.

Who is Rick Simpson, and Why Does His Story Matter to Ghana?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He was not a doctor. He was a power engineer and maintenance worker—a blue-collar tradesman whose path into cannabis advocacy began not with research, but with personal suffering.

In 1997, while working at a hospital in Moncton, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine could not resolve. The medications he was prescribed either failed to help or made his condition worse. Cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe it, the request was refused.

Sound familiar? In Ghana, many people face this exact pattern: workplace injuries, chronic post-injury symptoms, prescription cycles that don’t work, and doctors who dismiss cannabis as an option. The experience of being told “no” by a doctor resonates everywhere—whether you’re in Accra, Kumasi, or anywhere else. Simpson’s story is not just a Canadian tale; it’s a universal story of medical system failure that Ghanaian readers will recognize immediately.

Simpson’s interest deepened after learning about a 1974 study funded by the National Institute of Health, where THC was reported to slow or shrink tumors in mice. That study—originally intended to demonstrate harm—became his foundational reference point, even though its findings were never replicated in controlled human cancer trials.

The pivotal moment that created RSO: In 2003, Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. Important context: No independent medical verification has been published. No biopsy confirmation exists in any peer-reviewed source. This was personal testimony, not medical evidence—but it became the origin story of Rick Simpson Oil and the catalyst for a global movement.

The Crusade: Spreading the Oil

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia.

In Ghana, these conditions affect millions. Whether you’re in a rural village outside Kumasi or a urban neighborhood in Accra, you know someone battling one of these illnesses. The fact that Simpson gave his oil away for free connects directly to our open-source philosophy at OilWell: if you cannot afford our products, we publish the complete formula so you can source ingredients and make your own version. This continuity matters—it’s about accessibility, not just commerce.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, which was distributed freely online and became foundational in cannabis communities worldwide. Within Ghana’s growing online health-information communities, this film likely introduced many people to the concept of concentrated cannabis oil as medicine.

Legal Conflict and the Evolution of RSO

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Eventually, he left Canada for Europe, continuing his advocacy from Croatia and the Netherlands.

In Ghana, the legal landscape for cannabis is complex. While traditional uses exist, modern regulatory frameworks are evolving. We respect that every Ghanaian reader must understand and comply with their local laws. What we offer is a product legal under the 2018 U.S. Farm Bill—hemp-derived, with less than 0.3% delta-9 THC at the point of sale. This makes it shippable to Ghana, but you are responsible for verifying local legality before ordering. We provide full documentation, Certificates of Analysis, and receipts for customs purposes, but you must accept all customs and legal responsibility.

The Traditional RSO Protocol: Understanding What You’re Reading About

Simpson’s core recommendation was a 60-gram oral protocol over approximately 90 days. For Ghanaian readers researching online, this is the dosing schedule you’ll find in forums and patient groups. Here’s the full breakdown:

Week 1: Start with a dose the size of half a grain of rice—roughly 10-15 mg of oil—three times daily. Total daily intake: 30-45 mg.

Weeks 2-5: Double the dose every four days, gradually building tolerance. By week 5, the target is 1 gram (1,000 mg) of oil per day, divided into three doses.

Weeks 5-12: Maintain 1 gram per day until all 60 grams are consumed.

Administration methods: Simpson recommended sublingual/oral as primary, topical for skin cancers, and acknowledged inhalation for symptom relief but not as primary treatment.

Important context for evaluating this protocol:

• No controlled trial validation. Zero published randomized controlled trials, cohort studies, or well-documented case series.
• Very high THC exposure. At peak dosing, patients consumed 600-900 mg of delta-9 THC daily—a dose far exceeding anything studied clinically. The FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5-20 mg per day.
• Real risks. Consuming 600-900 mg of THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [15]. These risks are documented in the research literature.
• Oncology complexity. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as a primary treatment—potentially in place of proven therapies—introduces genuine harm potential.

We present this protocol because Ghanaian readers deserve complete information, not because we endorse it. Understanding the original protocol helps you evaluate what’s being sold locally and why OilWell’s modern approach is fundamentally different—and safer.

What Traditional RSO Actually Was

Traditional RSO was defined by Simpson’s method, not lab specifications:

• Source material: Single high-THC indica strain, no standardization
• Extraction solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol—neither food-grade
• Process: Bucket, solvent, agitate, filter, rice cooker evaporation (8 steps)
• Appearance: Nearly black, thick, tar-like oil with strong cannabis odor
• Cannabinoid profile: THC-dominant (60-90% estimated), fully decarboxylated, no ratio control, never lab-verified
• Terpene content: Minimal to none—destroyed by heat
• Standardization: None. Every batch was different.
• Residual solvent risk: Significant. Naphtha may contain benzene, toluene, and other carcinogens.

The gap between what people think RSO is (standardized medicine) and what it actually was (crude, variable, untested extract) is critical for Ghanaian consumers to understand. If you walk into a shop in Accra or search online in Ghana and see “RSO,” you need to know it probably isn’t what Simpson made—and that might be a good thing.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many other diseases. He encouraged patients to use it instead of proven therapies. This is where we must be brutally honest:

What the preclinical literature shows: In vitro studies demonstrate THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines. Animal models show some tumor-growth inhibition. This is scientifically interesting but not proof of human cancer cures.

What the preclinical literature does NOT show: No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer. The gap between in vitro/animal results and human outcomes is vast.

Institutional positions:

• U.S. National Cancer Institute: Acknowledges preclinical cannabinoid anticancer research but does not endorse cannabis as cancer treatment.
• FDA: Has not approved any cannabis plant product for cancer. Only Epidiolex (CBD) for seizures and synthetic THC analogues for chemo nausea/AIDS wasting are approved.
• Health Canada: Never approved RSO for cancer.

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world was ignoring it. His advocacy helped create the conditions for the legal cannabis industry.

What he overstated: Cure claims exceeded the evidence. Encouraging patients to rely on RSO instead of proven oncologic therapies carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern.

For Ghanaian cancer patients and caregivers reading this: We see you. We know the desperation. We know the fear when conventional medicine says there’s nothing more. We believe cannabinoids have supportive potential, but we will never tell you to replace proven treatment with RSO. Our position is that RSO education complements medical care—it does not replace it. If you’re in Ghana and facing cancer, we strongly encourage consulting your oncologist at Korle-Bu Teaching Hospital, Komfo Anokye Teaching Hospital, or your regional medical center alongside any cannabinoid exploration.

The OilWell Story: From Bentley’s Miracle to Ghana’s Access

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But to understand why our RSO formula matters for Ghana, you need to understand where Colin came from.

He grew up in McAllen, Texas—right across the river from Reynosa, Mexico, in one of North America’s most economically challenged and dangerous border regions. McAllen is a city of contrasts: vibrant culture alongside deep poverty, limited opportunities outside retail and healthcare. Reynosa is an industrial hub plagued by cartel violence. Colin’s childhood was marked by transporting items across the border for various groups—risky work that exposed him to every form of violence imaginable. By sixteen, he had to leave home for good. Many of his best friends have been killed or are in prison because of those dangers.

Despite this, Colin did not fall into the darkest paths. He chose cannabis as a safer alternative. He grew up in the traditional cannabis world pre-legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned to building a legal, legitimate business.

He later became a formally trained software engineer and did custom development work for Baylor College of Medicine—one of America’s most prestigious medical institutions. That combination of deep plant knowledge and medical-grade technical precision defines our approach.

Bentley: The Miracle That Started Everything

The company’s origin story begins with a dog named Bentley. Bentley was more than a pet—he was family. When veterinarians delivered the verdict no owner wants to hear—euthanasia was the only humane option, paralysis was irreversible, pain meds would destroy his organs—Colin refused to accept it.

In a desperate search for alternatives, a rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

That question changed everything. Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It wasn’t a cure, but it was hope. And that hope delivered what veterinary medicine said was impossible: Bentley got up. He walked over and brought Colin his ball to play.

Dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure
• Crippling arthritis → Multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

For Ghanaian pet owners: We understand the bond. In Ghana, where dogs guard compounds and are part of the family, Bentley’s story resonates deeply. We published the exact CBD golden paste recipe that saved Bentley on our website, free for anyone to make. If your companion in Kumasi, Accra, or Takoradi is suffering, you have options beyond euthanasia.

Original Bentley Golden Paste Recipe:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup unrefined coconut oil
• 1-2 tsp freshly ground black pepper (for absorption)
• CBD oil (dosage depends on size/needs; consult a vet)

Mix turmeric and water over low heat into a thick paste (7-10 minutes). Add coconut oil and pepper. Cool, refrigerate up to two weeks. Mix CBD oil in before serving. Start low, monitor your pet, consult a vet.

Colin’s Personal Battle: From Xanax Addiction to Peace

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a feat notoriously difficult and dangerous—using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula was created during midnight experiments fighting through benzo withdrawal. To ensure quick relief, we also offer Peace Gummies in vape form, which Colin personally uses to manage his insomnia and severe PTSD.

This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

For Ghanaians facing similar struggles—whether veterans in Tamale with combat trauma, survivors of road accidents in Accra, or anyone trapped in prescription cycles—this is real hope grounded in lived experience, not corporate marketing.

From Custom Formulas for Doctors to Ghanaian Access

Over time, the therapeutic benefits Colin discovered through Bentley became the core of his work. He developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible and effective for everyone—including vegans, diabetics, and those with specific health needs.

ABC13 Houston featured OilWell in seven comprehensive news segments from 2019 to 2023, covering Texas marijuana law, Delta-8 legal analysis, COVID community health leadership, criminal justice reform, and cannabis business pioneering. Colin was repeatedly selected as the primary industry expert in America’s fourth-largest city.

This media record isn’t marketing—it’s third-party verification. When you read this guide in Ghana, know that major American news organizations independently sought Colin’s expertise because of his integrity and knowledge.

Our Foundational Philosophy: The Quote That Defines Us

From Colin’s first ABC13 interview in September 2019:

“I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

That is OilWell’s promise to Ghana. We will give you the best possible version of the information. You decide if it’s right for you.

Modern Operations: Transparency You Can Verify

OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). Since 2019, we’ve generated approximately $1 million in annual revenue, maintain a near-5.0 Google rating, and hold a Texas DSHS license. All artwork, formulations, and packaging are created in-house in Houston using only our own recipes and ideas.

This matters for Ghanaian customers because you need to know you’re dealing with a real, successful, licensed business—not a fly-by-night operation. Our address, ratings, and license are verifiable public records. When you order from Ghana, you’re ordering from a company with four years of documented success, not an anonymous online brand.

The OilWell RSO Philosophy: Four Principles for Ghana

OilWell’s RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product that is informed by the RSO tradition but deliberately different in ways that solve the problems that limited Simpson’s original vision.

1. Accessibility Over Gatekeeping

No medical card required. Age 21+ only. Anyone who meets the age requirement can purchase. We ship nationwide across the United States and internationally to customers who verify local legality—including Ghana.

Simpson believed medicine should be accessible to everyone. OilWell built a product and distribution model that makes that accessible legally. In Ghana, where medical cannabis programs are limited or non-existent, this legal pathway through hemp-derived THCa is transformative.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to activate it.

Traditional RSO was always fully psychoactive—Simpson’s heating process converted all THCa to THC. Our sublingual formula includes 1,500 mg of THCa as a distinct ingredient. You have three options:

• Raw (no heat): All 1,500 mg stays as THCa—completely non-psychoactive. Use it during the day for anti-inflammatory benefits while working, driving, or parenting. THCa shows potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12].

• Fully activated (home decarboxylation): Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get ~1,405 mg total delta-9 THC. This achieves psychoactive potency comparable to traditional illegal RSO—100% legally, because activation happens at your discretion after purchase.

• Partial activation: Transfer a controlled portion to a second container and decarb only what you intend to use, preserving the remainder raw.

• Vape (instant activation): Our RSO Vape Cartridge operates at 400-450°F, instantly converting THCa to delta-9 THC with each puff. This is the fastest RSO delivery method available (1-2 minute onset).

The conversion chemistry: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation (reflecting the loss of a CO₂ molecule).

This design puts potency control entirely in your hands—aligning with Simpson’s principle that patients should control their medicine, but implementing it through actual chemistry rather than rhetoric.

3. Open-Source Formulas

We publish our complete formulas publicly—every cannabinoid, every milligram, every percentage. If you cannot afford our product, you can see exactly what it contains, source the individual cannabinoid distillates, and make your own version.

Simpson gave his oil away free and taught people how to make it. He never patented his method. We adapted that ethos for the modern cannabinoid marketplace: sell a professionally manufactured, lab-tested, standardized product for those who want it, and publish the complete recipe for those who want to make it themselves.

This open-source philosophy did not start with RSO—it started with Bentley. We published the exact CBD golden paste recipe that saved Bentley’s life, free for any pet owner facing a similar crisis. The pattern is consistent: we give away the formulas that matter most.

For Ghanaian makers and DIY communities, this is revolutionary. You don’t need to reverse-engineer products or trust unverified online recipes. You have our exact formula, tested over four years, used by doctors, validated by media.

4. Evidence-Informed, Not Evidence-Overstating

The extensive research section that follows represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature. We have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

We do not exempt ourselves from the same evidence standards we apply to the broader field. When we cite research in this guide, it’s from peer-reviewed sources. When we say evidence is weak, we mean it. When we say something is proven, we can point to the clinical trials.

For Ghanaian readers navigating a sea of misinformation, this is your anchor.

Farm Bill Compliance and the THCa Legal Framework for Ghana

The 2018 U.S. Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our product design.

Our RSO Sublingual Oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle (3 mg/mL)—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under U.S. federal law and in most states.

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

Practical significance for Ghanaian customers: You can legally purchase, possess, and transport our THCa-containing product. You then activate it through heating in your private setting in Ghana. This means the same legal product can function as non-psychoactive anti-inflammatory OR full-potency psychoactive cannabinoid medicine—entirely at your discretion.

Important legal notice: THCa converts to delta-9 THC when heated. Ghanaian customers are responsible for understanding and complying with Ghanaian laws regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility. We cannot guarantee delivery through Ghana Customs—please research your local import regulations before ordering.

We recommend contacting Ghana’s Narcotics Control Board or reviewing the Narcotic Drugs (Control, Enforcement and Sanctions) Law to understand current regulations. While our product meets U.S. legal standards, you must ensure compliance with Ghanaian law.

Delivery to Ghana: How You Can Access Our Products

We operate the only same-day RSO delivery system in Houston, but for Ghanaian customers, we offer comprehensive international shipping.

International Shipping to Ghana:

• We ship via USPS Priority Mail International, FedEx International, or DHL (5-14 business days typical)
• All packages include full documentation, Certificates of Analysis (COAs), and commercial invoices
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for long transit times
• Minimum flat-fee shipping applies (typically $35-65 USD depending on weight and service)
• Customer responsibility: You must verify legality in Ghana and accept all customs duties, taxes, and seizure risk

How to Order from Ghana:

1. Visit our website: oilwellcbd.com
2. Select your products (RSO Sublingual Oil $129.99, RSO Vape Cartridge $49.99)
3. Enter your Ghanaian shipping address (Accra, Kumasi, Takoradi, etc.)
4. Complete payment (we accept international credit cards)
5. We ship within 1-2 business days
6. Track your package and monitor customs clearance

Pro Tip for Ghanaian Customers: Contact us at [email protected] or WhatsApp +1 (832) 416-2816 before ordering. We can provide guidance on documentation, answer customs questions, and ensure your package is prepared appropriately for Ghanaian import regulations.

The significance for Ghana: Rick Simpson could not ship his oil anywhere—it was Schedule I, illegal to produce, possess, or transport. Today, a cancer patient in Accra, a chronic pain sufferer in Kumasi, or a veteran in Tamale can potentially access the same clinical-strength multi-cannabinoid RSO formula that a Houston resident receives via same-day delivery. We built a product that can move across borders legally—completing a piece of Rick Simpson’s vision that prohibition made impossible.

The Evidence Base: What Science Actually Says

This is where OilWell differs from every other RSO provider. We don’t cherry-pick studies. We present the evidence hierarchy honestly.

CBD: The Most Studied Non-Psychoactive Cannabinoid

Strongest human evidence:

• Seizure disorders: Epidiolex (purified CBD) is FDA-approved for certain rare epilepsies. This is the clearest major-example indication acknowledged by institutional literature [1][2].

Anxiety: A 2024 systematic review and meta-analysis covering 316 participants across eight studies reported statistically significant anxiolytic effects, but authors stressed the clinical sample remains limited and more trials are needed before broad conclusions are justified [3].

Pain: A 2024 systematic review of CBD monotherapy concluded the pain literature is promising but heterogeneous, with trial quality limiting confidence in broad analgesic claims [4].

Sleep: A 2023 insomnia review found the literature remains methodologically weak, with many studies relying on nonvalidated subjective measures [5].

Safety concerns: A 2023 systematic review found a real signal for liver enzyme elevation and possible drug-induced liver injury in some CBD contexts, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH also flags diarrhea, sleepiness, appetite changes, mood effects, and drug-drug interactions [1].

For Ghanaian readers: If you have liver conditions, are taking multiple medications (common for chronic disease management in Ghana), or are pregnant, consult your doctor before using high-dose CBD products.

CBG: The “Mother Cannabinoid” with Promise

Evidence profile: Mostly review-level and preclinical; human evidence remains sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids and interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling—mechanistically interesting but not clinically established [7].

Research areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are pharmacology-led hypotheses, not mature human therapeutic conclusions [7][8].

Bottom line: CBG is a promising minor cannabinoid with limited clinical validation. It’s commercially interesting precisely because it’s underexplored, which means claims often outrun the science [7][8].

Our formula includes 3,000 mg of CBG because the preclinical signal is strong enough to justify inclusion in a multi-cannabinoid approach, but we won’t claim it’s a proven therapy.

Delta-8 THC: Not “THC-Lite”

Evidence profile: Pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC [9]-[11].

Comparative pharmacology: A 2022 review concluded delta-8 and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 is a partial CB1 agonist with cannabimimetic activity, but appears less potent—likely due to weaker CB1 affinity [9].

Public health concerns: A 2023 scoping review found the delta-8 evidence base is dominated by animal studies, product chemistry, and use reports rather than strong human trials. Reports of adverse consequences emphasize regulatory and product-quality concerns [10].

Manufacturing context: Commercial delta-8 interest is tied to easier synthesis relative to naturally scarce plant levels, which raises lab-testing and byproduct questions [11].

Bottom line: Delta-8 THC is a psychoactive THC analogue with real pharmacologic activity and incomplete human safety characterization. Our formula includes 6,000 mg because it offers a legal pathway to meaningful THC-family effects, but you must treat it with the same respect as delta-9 THC.

For Ghanaian customers: If you choose to decarboxylate our THCa, you’ll create approximately 1,315 mg delta-9 THC. Combined with our 6,000 mg delta-8 THC, the activated product delivers significant psychoactive cannabinoid exposure. Do not operate vehicles or machinery after activation. If you work in transport, construction, or safety-sensitive jobs in Ghana, use the raw form during work hours.

THCa: The Legal Innovation

What it is: THCa is the acidic precursor of THC. It may represent a large share of THC-related content in raw cannabis. It decarboxylates into THC during heating and can change during storage [12].

Psychoactivity: THCa itself does not produce psychoactive effects, but the distinction only holds if the molecule stays acidic and is not substantially decarboxylated [12].

Research status: In vitro and rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not established human outcomes [12].

Why this matters for Ghana: THCa is the key to legal access. Because it’s Farm Bill compliant at sale but convertible to THC at home, you can legally purchase a product that becomes high-potency psychoactive medicine through your own action. This is the most significant legal cannabis access innovation in modern history—backed by actual chemistry, not loopholes.

Our formula includes 1,500 mg THCa—enough to create ~1,315 mg delta-9 THC after decarboxylation, while still keeping the pre-sale product under 0.3% delta-9 THC.

Delta-9 THC: The Most Researched Psychoactive Cannabinoid

Evidence profile: Strongest human evidence of the psychoactive cannabinoids, but also the clearest adverse-effect burden [1][13]-[15].

Institutionally supported uses: NCCIH identifies THC-containing medicines as relevant to chemotherapy-related nausea/vomiting, HIV/AIDS-related appetite/weight loss, and some multiple-sclerosis- and pain-related outcomes [1].

Pain evidence: A 2022 systematic review found high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, and treatment discontinuation [13].

Pharmacokinetics: Inhaled THC: onset seconds-minutes, peaks 15-30 minutes, lasts few hours. Oral THC: later onset, later peak, longer duration—critical for avoiding overconsumption [14].

Mental health risk: A 2025 systematic review found consistent unfavorable associations between high-concentration THC products and psychosis/schizophrenia outcomes, with concerning signals for anxiety and depression [15].

Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, and vape-related lung injury concerns [1][14][15].

Our formula includes only 90 mg delta-9 THC in the entire bottle—3 mg/mL. This is intentionally low to provide mild baseline effects while letting THCa and delta-8 THC carry the therapeutic load. This dramatically reduces the risk profile compared to traditional RSO while maintaining potency potential through activation.

CBN: The Sleep Cannabinoid (With Weak Evidence)

Evidence profile: Weak human evidence; marketing has moved ahead of the data [12][16][17].

What it’s marketed for: Sleep and sedation. That reputation is widespread, but clinical support is far thinner than the market suggests [16][17].

Best review: A 2021 narrative review screened 99 human-study abstracts and found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].

Broader sleep literature: A 2024 review concluded that overall cannabinoid sleep research still doesn’t match real-world use scale, and better-designed trials are needed [17].

Bottom line: CBN is one of the clearest examples where cultural reputation is stronger than clinical evidence [16][17].

Our formula includes 750 mg CBN—delivering 25 mg per mL dose at the recommended 1 mL serving, which is above the 20 mg threshold associated with reduced sleep disturbance in the limited research. We include it because customer reports are positive, but we’re honest about the science gap.

CBC: The Emerging Neurogenerative Cannabinoid

Evidence profile: Emerging, intriguing, overwhelmingly preclinical [18][19].

Pharmacology: A 2024 focused review argues CBC has distinct pharmacodynamics and receptor behavior, highlighting antinociceptive, antibacterial, and anti-seizure areas as interesting research targets [18].

Older literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological relevance—but not strong evidence for patient claims [19].

Safety caveat: The 2024 CBC review explicitly notes over-the-counter CBC products are being sold despite little evidence establishing clinical efficacy or safety [18].

Bottom line: CBC is scientifically credible but clinically immature [18][19].

Our formula includes 750 mg CBC as part of our neuroprotective and anti-inflammatory synergy strategy.

Terpenes: The Entourage Effect (With Cautious Interpretation)

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. The 2024 entourage-effect review emphasizes: terpene bioactivity is plausible, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Still, our formula includes 5% live terpenes with a defined seven-terpene profile because the preclinical evidence is promising enough to justify inclusion in a multi-compound strategy.

Limonene (citrus-bright): Multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective properties in review literature [21]. Caution: Limonene oxidation products are contact allergens [22].

Myrcene: Anxiolytic, antioxidant, anti-inflammatory properties in preclinical work, but human studies are lacking [23]. The “sedating terpene” claim is stronger than evidence supports.

Caryophyllene (pepper/spice): Selective CB2 receptor agonist—unusual and pharmacologically interesting [24]. Anti-inflammatory, immunomodulatory, neuroprotective in reviews, but human confirmation limited [24].

Pinene (forest-fresh): Antioxidant, anti-inflammatory, neuroprotective signals justify future study, but well-designed human trials are lacking [25].

Linalool (floral, lavender): Stress and mood pharmacology in reviews, but mostly preclinical [25][26]. Caution: Oxidized linalool is a recognized allergen [22].

Humulene (earthy, woody): Preclinical anti-inflammatory evidence, some rodent work suggesting cannabimimetic properties, but not clinically settled [27].

Terpinolene (piney, fruity): Least clinically characterized. Review of 2,449 records found mostly in silico, in vitro, and animal studies [28]. Biologically interesting but underdeveloped.

The RSO Sublingual Oil Formula: Complete Transparency

This is our open-source formula. Every mg amount is published. Ghanaian makers can source these ingredients and reproduce it.

Cannabinoid	Amount
CBD (Cannabidiol)	4,500 mg
CBG (Cannabigerol)	3,000 mg
Delta-8 THC	6,000 mg
THCa (Tetrahydrocannabinolic Acid)	1,500 mg
Delta-9 THC	90 mg
CBN (Cannabinol)	750 mg
CBC (Cannabichromene)	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5% (Limonene, Myrcene, Caryophyllene, Pinene, Linalool, Humulene, Terpinolene)
• Format: 30 mL bottle with graduated dropper (0.1 mL increments)
• Active cannabinoids per mL: 553 mg
• Carrier: Organic MCT oil
• Onset: 15-45 minutes (sublingual)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (partially bypasses first-pass liver metabolism)
• Doses per bottle: Approximately 40-60 depending on serving size

The RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1-gram 510-thread cartridge (universal battery compatibility)
• Onset: 1-2 minutes (inhalation)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable by inhalation technique)
• Automatic THCa decarboxylation: Occurs at vaping temperature (400-450°F)

Condition-Specific Usage Contexts for Ghana

Important Disclaimer: These usage contexts are informed by cannabinoid research cited above. They are not medical prescriptions, not FDA-approved treatment protocols, and not substitutes for professional medical care. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support (For Ghanaian Cancer Patients)

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea/vomiting evidence [1][13], CBD anxiolytic buffering [3]

For Ghanaian patients: If you’re receiving chemo at Korle-Bu Teaching Hospital, Komfo Anokye Teaching Hospital, or any regional facility, discuss cannabinoid use with your oncologist. Our product can complement conventional anti-nausea protocols, not replace them. The raw THCa option allows daytime use without impairment during treatment cycles.

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy, Common in Ghanaian Elders)

• Daytime functional relief: 0.3-0.5 mL raw sublingual—provides anti-inflammatory cannabinoid exposure without psychoactive impairment, allowing you to work, drive, and parent
• Nighttime relief: 0.5-1.0 mL decarboxylated sublingual—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

For Ghanaian pain sufferers: Whether your pain comes from years of physical labor, diabetic neuropathy, or inflammatory arthritis, the multi-cannabinoid approach targets multiple pathways simultaneously—something single-cannabinoid products cannot do.

Sleep Support (For Ghana’s Many Insomnia Sufferers)

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: Delivers 50 mg CBN—the dosage investigated in 2024 sleep literature
• At 1.0 mL: Delivers 25 mg CBN—above the 20 mg threshold associated with reduced sleep disturbance

Evidence context: CBN sleep evidence [16][17], cannabis and sleep review literature

For Ghanaian customers: We are honest about CBN’s weak evidence base. Many Ghanaian consumers report sleep benefits, but the science is not yet definitive. Start with 1 mL and assess your response. Combine with good sleep hygiene: consistent bedtime, dark room, limit screen time.

Anxiety and Stress (For Ghana’s High-Pressure Urban Environment)

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual—full cannabinoid profile including CBN for sleep architecture

Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage effect [20]

For Ghanaians in Accra and Kumasi: Workplace stress, traffic, economic pressures—these take a toll. The raw THCa option gives you daytime support without affecting job performance.

General Titration Principle for Ghana: Start Low, Go Slow

Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and genetics. Ghanaian pharmacogenomics may differ from Western populations—your response might be stronger or weaker than reported averages.

How to Order from Ghana: Step-by-Step

1. Visit our website: oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
2. Select products: RSO Sublingual Oil ($129.99) and/or RSO Vape Cartridge ($49.99)
3. Enter shipping address: Your complete Ghanaian address including region (e.g., Greater Accra, Ashanti Region, Western Region)
4. Complete payment: International credit cards accepted
5. Contact us: Email [email protected] or WhatsApp +1 (832) 416-2816 to confirm your order and discuss customs documentation
6. We ship: Within 1-2 business days with full COAs
7. Track: Monitor your package through USPS, FedEx, or DHL
8. Customs clearance: You may need to provide COAs to Ghana Customs. We include all paperwork, but you are responsible for clearance.

Shipping Time to Ghana: Typically 7-21 business days depending on service level and customs processing.

Customs Duties: Expect to pay import duties based on Ghana’s tariff schedule for “health supplements” or “herbal extracts.” We cannot prepay these—they are your responsibility upon delivery.

Risk: We cannot guarantee delivery through Ghana Customs. Some packages may be seized if local officials interpret the product differently. We provide all documentation, but customs decisions are beyond our control. Order at your own risk, after researching local regulations.

Media Recognition: Third-Party Verification of Our Credibility

Between 2019 and 2023, ABC13 Houston featured OilWell Cannabis in seven news segments—more than any other Houston cannabis operator. Five different reporters sought Colin out. This coverage spans business, law, medicine, community health, and politics.

What this means for Ghanaian customers: You don’t have to take our word for our credibility. Major American media organizations independently verified our story, our expertise, and our community impact. When you’re considering a purchase from Ghana, this third-party validation is crucial.

Key features that establish our character:

• September 2019: First feature, where Colin stated our foundational philosophy about not selling snake oil
• August 2021: $35,000 in free product donated to encourage COVID vaccination—community action documented on camera
• October 2021: When Delta-8 became illegal overnight, Colin proactively removed all products and warned other operators before enforcement began—ethical leadership in crisis
• October 2022: Revealed Colin’s personal marijuana conviction history—transparency about lived experience with criminalization
• April 2023: Positioned as industry authority on Texas cannabis policy—demonstrating sustained relevance

These features cannot be purchased—they can only be earned. For Ghanaian customers wary of online scams, this record proves we’re a legitimate operation with documented integrity.

Frequently Asked Questions from Ghana

Q: Is this legal to import into Ghana?
A: Our product is Farm Bill compliant in the U.S., containing less than 0.3% delta-9 THC at sale. However, Ghanaian law regarding hemp-derived cannabinoids is evolving. You must research current regulations with Ghana’s Narcotics Control Board. We provide full documentation, but you accept all customs and legal responsibility.

Q: Will this cure my cancer?
A: No cannabinoid product has been proven to cure cancer in humans. Preclinical studies are interesting but not conclusive. Do not replace proven cancer treatment with RSO. Our product may help with symptom management (pain, nausea, sleep), but it is not a cure.

Q: Can I use this while taking other medications?
A: CBD and other cannabinoids can interact with medications, especially those metabolized by the liver. If you’re taking antiretrovirals, antimalarials, or other common Ghanaian medications, consult your doctor first.

Q: How do I know your product is safe?
A: We provide third-party Certificates of Analysis for every batch, testing for potency, heavy metals, pesticides, residual solvents, and microbes. This is the safety standard that traditional RSO never had.

Q: Why is this expensive?
A: 16,590 mg total cannabinoids across seven compounds, lab-tested, Houston-made, with open-source formulas available for DIY. The concentration and quality justify the price. Compare to CBD-only products with 1,000 mg total for $40-50—our formula is 16x more concentrated and includes six additional cannabinoids.

Q: Can I make this myself in Ghana?
A: Yes. Our complete formula is published above. You would need to source CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC distillates/isolates, plus live terpenes and MCT oil. This is feasible but requires careful sourcing and measurement. Our product offers convenience, precision, and safety testing.

Q: How long does shipping to Ghana take?
A: Typically 7-21 business days depending on customs processing. Contact us before ordering to discuss documentation.

Q: What if Ghana Customs seizes my package?
A: We cannot guarantee customs clearance. We provide all required paperwork, but customs decisions are beyond our control. Order at your own risk after researching local laws.

Safety Warnings and Disclaimers for Ghana

• Age requirement: 21+ only
• Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids
• May cause drowsiness or impairment—plan your dosing schedule accordingly
• Consult your healthcare provider before use if you have medical conditions, take medications, are pregnant or nursing
• Keep out of reach of children—the product looks like honey and could be attractive to kids
• Store in cool, dark place—Ghana’s heat can accelerate THCa decarboxylation. Keep refrigerated if possible
• Individual results may vary—Ghanaian pharmacogenomics may produce different responses than Western populations
• Not evaluated by FDA—not intended to diagnose, treat, cure, or prevent any disease
• Buyer responsibility to verify Ghanaian law before ordering

Conclusion: An Invitation to Ghana

Rick Simpson’s story began with a man failed by the medical system, who found hope in cannabis and shared it freely with others. OilWell’s story began with a dog named Bentley, who got up from paralysis and lived ten more years because his owner refused to accept euthanasia and discovered cannabinoid medicine.

Both stories share a common thread: when conventional medicine falls short, cannabis can offer hope—but only if it’s honest, safe, and accessible.

For Ghanaian readers, we offer something unprecedented:

• Complete formula transparency—no secrets, no hype
• Legal international shipping—hemp-derived THCa compliance
• Patient-controlled potency—you decide psychoactive or not
• Evidence-based education—what works, what doesn’t, what’s unknown
• Community-tested formulations—used by doctors, veterans, and chronic illness patients
• Third-party media verification—ABC13’s sustained coverage proves our credibility

Whether you’re in Accra exploring options for a family member with cancer, in Kumasi managing chronic pain, in Tamale seeking PTSD relief, or anywhere in Ghana simply wanting to understand what RSO actually is—we see you, we respect you, and we’re here to educate, not exploit.

Order today at oilwellcbd.com or contact us directly at [email protected] / WhatsApp +1 (832) 416-2816 with your Ghana-specific questions.

We don’t sell snake oil. We don’t sell hope. We sell the best possible version of the information and product, so you can give it a fair shot and decide for yourself whether it’s right or wrong for you.

The mission that started when Bentley got up continues now—with you in Ghana.

---